BRITTANY SPIVEY: Open Payments
NPI 1063178648 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,388 in 85 payments from 14 companies in 2025. Trend: 2023 $414 · 2024 $1,884 · 2025 $1,388
Food & beverage: $1,388
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $335 |
| Janssen Biotech, Inc. | 11 | $169 |
| Ipsen Biopharmaceuticals, Inc | 7 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $146 |
| Regeneron Healthcare Solutions, Inc. | 6 | $107 |
| GENZYME CORPORATION | 5 | $92 |
| Celltrion USA Inc. | 4 | $72 |
| Gilead Sciences, Inc. | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 5 | $61 |
| Aimmune Therapeutics, Inc. | 3 | $50 |
Products named: DUPIXENT, TREMFYA, CREON, IQIRVO, ENTYVIO, VEGZELMA, LINZESS, VOQUEZNA.
Industry payments across IA — which companies pay providers there.
